HALEON has launched the Australian chapter of the Haleon Pain Management Institute, an expert-led collaboration with a focus on improving pain outcomes for local patients by prioritising research and scientific innovation, healthcare professional education, and patient self-care.
The three priority areas are paediatric pain management, mobility health and pharmacist education, with leading clinical and pharmacy experts coming together to support the community and industry.
The Institute will partner with pharmacists to create resources to help support managing children's pain at home and in community settings.
Senior clinical pharmacist Nicolette Ellis, chair of Chronic Pain Australia and Haleon Pain Management Institute expert advisor, said: "Pharmacists are often the first point of contact for families managing pain in children.
"A priority for the Institute will be the development of actionable and insight-driven patient-centred education materials that support the quality use of medicines and build caregiver confidence in pain management," she explained.
The Institute will also develop self-care resources for the more than two million Australians affected by osteoarthritis, using clinical and academic expertise to create practical frameworks that support healthcare professionals in helping patients with mobility issues maintain movement and manage pain effectively.
Meanwhile, the company has launched new and improved flavours of paracetamol liquid suspensions, with tutti frutti added to the reformulated orange and strawberry flavours.
The new formulations have been developed with a focus on an improved taste to help make medicine time easier for both parents and children. KB
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Mar 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Mar 26
